Clinical trial
Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
NCT00339001 · Sheba Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00339001 |
|---|---|
| Title | Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity |
| Official title | The Possible Influence of Erythropoietin and Early Iron Supplements on the Prevalence and Severity of Retinopathy of Prematurity and Other Short Term Outcome of Prematurity |
| Lead sponsor | Sheba Medical Center, Other |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Retinopathy of Prematurity |
| Intervention type | Drug |
| Interventions | erythropoietin and early iron supplements |
| Enrollment | 400 |
| Start date | Apr 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Jun 20, 2006 |
| Last update posted | Jun 20, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: